Literature DB >> 17616656

Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family.

Cecilia Garlanda1, Federica Riva, Tania Veliz, Nadia Polentarutti, Fabio Pasqualini, Enrico Radaelli, Marina Sironi, Manuela Nebuloni, Elisabetta Omodeo Zorini, Eugenio Scanziani, Alberto Mantovani.   

Abstract

TIR8 (also known as SIGIRR) is a member of the interleukin-1/Toll-like receptor family with inhibitory activity on inflammatory reactions and high expression in intestinal mucosa. Here, we report that Tir8-deficient mice exhibited a dramatic intestinal inflammation in response to dextran sulfate sodium salt (DSS) administration in terms of weight loss, intestinal bleeding, and mortality and showed increased susceptibility to carcinogenesis in response to azoxymethane and DSS. Increased susceptibility to colitis-associated cancer was associated to increased permeability and local production of prostaglandin E(2), proinflammatory cytokines, and chemokines. Thus, these results are consistent with the hypothesis that TIR8, by negatively regulating intestinal inflammation, plays a nonredundant role in the control of the protumor activity of chronic inflammation in the gut.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616656     DOI: 10.1158/0008-5472.CAN-07-0560

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

1.  STAT2 contributes to promotion of colorectal and skin carcinogenesis.

Authors:  Ana M Gamero; Matthew R Young; Roycelynn Mentor-Marcel; Gerd Bobe; Anthony J Scarzello; Jennifer Wise; Nancy H Colburn
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-16

2.  Differential regulation of Toll-like receptor signalling in spleen and Peyer's patch dendritic cells.

Authors:  Julie M Davies; John MacSharry; Fergus Shanahan
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

3.  Down-regulation of single immunoglobulin interleukin-1R-related molecule (SIGIRR)/TIR8 expression in intestinal epithelial cells during inflammation.

Authors:  C Kadota; S Ishihara; M M Aziz; M A Rumi; N Oshima; Y Mishima; I Moriyama; T Yuki; Y Amano; Y Kinoshita
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

Review 4.  Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria.

Authors:  Chen Varol; Ehud Zigmond; Steffen Jung
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

Review 5.  Cancer in inflammatory bowel disease: lessons from animal models.

Authors:  Daniel A Sussman; Rebeca Santaolalla; Sebastian Strobel; Rishu Dheer; Maria T Abreu
Journal:  Curr Opin Gastroenterol       Date:  2012-07       Impact factor: 3.287

Review 6.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

7.  The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response.

Authors:  Katarzyna Bulek; Shadi Swaidani; Jinzhong Qin; Yi Lu; Muhammet F Gulen; Tomasz Herjan; Booki Min; Robert A Kastelein; Mark Aronica; Magdalena Kosz-Vnenchak; Xiaoxia Li
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

Review 9.  Toll-like receptors in inflammatory bowel diseases: a decade later.

Authors:  Elke Cario
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

10.  The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker.

Authors:  Rosaria Cammarota; Valentina Bertolini; Giuseppina Pennesi; Eraldo O Bucci; Ornella Gottardi; Cecilia Garlanda; Luigi Laghi; Massimo C Barberis; Fausto Sessa; Douglas M Noonan; Adriana Albini
Journal:  J Transl Med       Date:  2010-11-08       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.